YTHDF1 targeting can be a viable option for cancer therapy, as its elevation promotes cancer growth in different cancers, including GC (85), ovarian cancer (106, 107), CRC (108), and HCC (109). The gene discussed is YTHDF1; the disease is gastric cancer.